Brain-Computer Interface-based Programme for the Treatment of ASD/ADHD (ASDBCI)

• Sponsor: Duke-NUS Graduate Medical School
• Collaborators: Institute of Mental Health, Singapore; Agency for Science, Technology and Research
• Information provided by (Responsible Party): Lee Tih Shih, Duke-NUS Graduate Medical School

Study Description

Brief Summary:

This project involves creating a novel and personalised BCI training system that targets social and communication difficulties, and inattentive symptoms problems often found in ASD/ADHD children. 20 participants between the age of 8 and 12 will be recruited and they will undergo 24 training sessions over an 8-week period. During these sessions, the children will play a computer game interface specifically designed to train attention and facial and emotional recognition, while using our BCI device. To further reinforce the treatment, the training system has been enhanced with the inclusion of an eye-tracker to target the lack of preferential eye contact that children with ASD exhibit. The investigators hypothesize that participants will show improvements in social skills and attention post treatment.

Condition or disease	Intervention/treatment	Phase
Attention Deficit Hyperactivity Disorder; Autism Spectrum Disorders	Other: Intervention Group; Other: Control Group	Not Applicable

  Show Detailed Description

Study Design

• Study Type: Interventional (Clinical Trial)
• Estimated Enrollment: 20 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Single (Outcomes Assessor)
• Primary Purpose: Treatment
• Official Title: Effectiveness of a Brain-Computer Interface-based Programme for the Treatment of Autism Spectrum Disorder and Attention Deficit Hyperactivity Disorder in Children: A Pilot Study
• Study Start Date: May 2016
• Estimated Primary Completion Date: August 2017
• Estimated Study Completion Date: July 2018

Arms and Interventions

Arm	Intervention/treatment
Experimental: Intervention Group; 10 child participants in the intervention group will take part in a total of 24 sessions spread over an 8-week period, and a final follow-up review 1 month after the completion of the training session. If sessions are missed during the 8-weeks period due to unforeseen circumstances (e.g. sickness, travel plans), arrangements will be made for participants to attend up to 5 BCI-based therapy sessions per week. All participants will have to complete a minimum of 20 sessions within the 8-weeks period for treatment efficacy.	Other: Intervention Group; Each participant will first need to master a simple concentration task before moving on to play a series of training tasks. An eye gaze tracker connected to the computer will detect the location of eye gaze on the computer screen. The game progresses according to how well the participant can focus their eye gaze on correct objects and sustain their attention. Each task employs the BCI system, and is controlled by the child's concentration. As the child attends to activities on a computer screen, their EEG waves will be recorded simultaneously via the EEG sensors through Bluetooth technology.; Other Name: BCI Training
Control Group; 10 child participants in the control group will not receive BCI training during the first 8 weeks of their study participation; they will act as controls. At week 9, subjects in this group will go through the BCI training similar to the intervention group. If sessions are missed during the 8-weeks period due to unforeseen circumstances (e.g. sickness, travel plans), arrangements will be made for participants to attend up to 5 BCI-based therapy sessions per week. All participants will have to complete a minimum of 20 sessions within the 8-weeks period for treatment efficacy. They will take part in a total of 24 sessions spread over an 8-week period, followed by a final follow-up review 1 month after the completion of the training sessions.	Other: Control Group; Participants will wait for 8 weeks before training intervention begins. Each participant will first need to master a simple concentration task before moving on to play a series of training tasks. An eye gaze tracker connected to the computer will detect the location of eye gaze on the computer screen. The game progresses according to how well the participant can focus their eye gaze on correct objects and sustain their attention. Each task employs the BCI system, and is controlled by the child's concentration. As the child attends to activities on a computer screen, their EEG waves will be recorded simultaneously via the EEG sensors through Bluetooth technology.; Other Name: Waitlist BCI Training

Outcome Measures

Primary Outcome Measures :

1. ADHD Rating Scale (clinicians) [ Time Frame: Week 1 to Week 8 ]
   The primary outcome of this study will be the change in the inattentive score on the ADHD Rating Scale as rated by the clinicians from week 1 to week 8.

Secondary Outcome Measures :

1. ADHD Rating Scale (parent) [ Time Frame: Week 1 to Week 8 ]
   The change in the inattentive score of the ADHD RS rated by parent from week 1 to week 8.
2. ADHD Rating Scale (clinician and parent) [ Time Frame: Week 1 to Week 8 ]
   The change in the inattentive score of the ADHD RS rated by clinician and parent from week 1 to week 8.
3. ADHD Rating Scale [ Time Frame: Week 1 to Week 8 ]
   The change in parent rated ADHD-RS from week 1 to week 8.
4. Social Responsiveness Scale [ Time Frame: Week 1 to Week 8 ]
   The change in parent rated SRS from week 1 to week 8.
5. Clinical Global Assessment Scale (C-GAS) [ Time Frame: Week 1 to Week 8 ]
   The change in clinician rated CGAS and CGI scores from week 1 to week 8.
6. Clinical Global Impression Severity Scale (CGI-S) [ Time Frame: Week 1 to Week 8 ]
   The change in clinician rated CGAS and CGI scores from week 1 to week 8.
7. Clinical Global Impression Improvement Scale (CGI-I) [ Time Frame: Week 1 to Week 8 ]
   The change in clinician rated CGAS and CGI scores from week 1 to week 8.
8. Conners' Continuous Performance Test (CPT-II) [ Time Frame: Week 1 to Week 8 ]

Other Outcome Measures:

1. Pediatric Adverse Event Rating Scale (PAERS) [ Time Frame: Week 8 ]

Eligibility Criteria

• Ages Eligible for Study: 8 Years to 12 Years (Child)
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Criteria

Inclusion Criteria:

• Meets diagnostic criteria for ASD, based on Autism Diagnostic Observation Scale (ADOS) and/or Diagnostic and Statistical Manual of Mental Disorders, 4th Edition, Text Revision (DSM IV-TR) / 5th edition (DSM 5);
• Meets diagnostic criteria for ADHD inattentive or combined subtype, based on the Computerised Diagnostic Interview for Children (C-DISC);
• Score 12 and above on the ADHD Rating Scale (ADHD-RS);
• IQ above 70;
• If on medication, dose has been stable or unchanged for at least preceding 3 months
• Parents and teachers are English-speaking

Exclusion Criteria:

1. Co-morbid severe psychiatric condition or known sensory-neural deficit e.g. complete blindness or deafness.
2. Color blindness
3. History of epileptic seizures.
4. Known to have developmental delay (i.e. IQ 70 and below).
5. Predominantly hyperactive/impulsive subtype of ADHD.
6. Change in dosage of medication (if on medication)

Contacts and Locations

Contacts

Contact: Tih-Shih Lee; 65167461; tihshih.lee@duke-nus.edu.sg

Locations

Singapore

Institute of Mental Health; Recruiting

Singapore, Singapore, 539747

Contact: Choon Guan Lim, MBBS, M Med 6389 2200 choon_guan_lim@imh.com.sg

Contact: Wendy Poh 6389 2200 Xue_Wei_POH@imh.com.sg

Sponsors and Collaborators

Duke-NUS Graduate Medical School

Institute of Mental Health, Singapore

Agency for Science, Technology and Research

Investigators

• Principal Investigator: Choon Guan Lim; Institute of Mental Health, Singapore

More Information

Publications:

Jang J, Matson JL, Williams LW, Tureck K, Goldin RL, Cervantes PE. Rates of comorbid symptoms in children with ASD, ADHD, and comorbid ASD and ADHD. Res Dev Disabil. 2013 Aug;34(8):2369-78. doi: 10.1016/j.ridd.2013.04.021. Epub 2013 May 22.

Rommelse NN, Franke B, Geurts HM, Hartman CA, Buitelaar JK. Shared heritability of attention-deficit/hyperactivity disorder and autism spectrum disorder. Eur Child Adolesc Psychiatry. 2010 Mar;19(3):281-95. doi: 10.1007/s00787-010-0092-x. Epub 2010 Feb 11. Review.

Coben R, Linden M, Myers TE. Neurofeedback for autistic spectrum disorder: a review of the literature. Appl Psychophysiol Biofeedback. 2010 Mar;35(1):83-105. doi: 10.1007/s10484-009-9117-y. Review.

Linden M, Habib T, Radojevic V. A controlled study of the effects of EEG biofeedback on cognition and behavior of children with attention deficit disorder and learning disabilities. Biofeedback Self Regul. 1996 Mar;21(1):35-49. Erratum in: 1996 Sep;21(3):297.

Gevensleben H, Holl B, Albrecht B, Vogel C, Schlamp D, Kratz O, Studer P, Rothenberger A, Moll GH, Heinrich H. Is neurofeedback an efficacious treatment for ADHD? A randomised controlled clinical trial. J Child Psychol Psychiatry. 2009 Jul;50(7):780-9. doi: 10.1111/j.1469-7610.2008.02033.x. Epub 2009 Jan 12.

Lim CG, Lee TS, Guan C, Sheng Fung DS, Cheung YB, Teng SS, Zhang H, Krishnan KR. Effectiveness of a brain-computer interface based programme for the treatment of ADHD: a pilot study. Psychopharmacol Bull. 2010;43(1):73-82.

Lee TS, Goh SJ, Quek SY, Phillips R, Guan C, Cheung YB, Feng L, Teng SS, Wang CC, Chin ZY, Zhang H, Ng TP, Lee J, Keefe R, Krishnan KR. A brain-computer interface based cognitive training system for healthy elderly: a randomized control pilot study for usability and preliminary efficacy. PLoS One. 2013 Nov 18;8(11):e79419. doi: 10.1371/journal.pone.0079419. eCollection 2013.

Jones W, Carr K, Klin A. Absence of preferential looking to the eyes of approaching adults predicts level of social disability in 2-year-old toddlers with autism spectrum disorder. Arch Gen Psychiatry. 2008 Aug;65(8):946-54. doi: 10.1001/archpsyc.65.8.946.

• Responsible Party: Lee Tih Shih, Associate Professor, Duke-NUS Graduate Medical School
• ClinicalTrials.gov Identifier: NCT02618135 History of Changes
• Other Study ID Numbers: 2015/00841
• First Posted: December 1, 2015
• Last Update Posted: August 2, 2017
• Last Verified: July 2017

Additional relevant MeSH terms:

Autism Spectrum Disorder; Disease; Attention Deficit Disorder with Hyperactivity; Hyperkinesis; Child Development Disorders, Pervasive; Pathologic Processes; Attention Deficit and Disruptive Behavior Disorders; Neurodevelopmental Disorders; Mental Disorders; Dyskinesias; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms